A 28-year-old woman with newly diagnosed pulmonary TB is started on standard first-line antitubercular therapy. She is on oral contraceptives (ethinylestradiol + levonorgestrel). After 6 weeks of therapy, she reports breakthrough bleeding and is concerned about contraceptive failure. Which antitubercular drug is responsible for this interaction, and what is the mechanism?